1 min left

0% read

Multiplier AI

Media

Software

Technology Company

Danville, California, USA

Founded 2016

106

Transforming Healthcare with Innovation

Multiplier AI is a leading force in the healthcare industry, providing cutting-edge solutions to global brands like Galderma, Abbott, Merck, Cipla, Mankind, and more. With a team of 70+ dedicated professionals, we specialize in generative AI, data insights, and physician influencer marketing, driving growth and transformation in the healthcare landscape.

Our Expertise: Generative AI and Personalized Marketing

Our expertise lies in harnessing the power of generative AI to create personalized, impactful marketing campaigns. Through advanced algorithms, we generate compelling content, captivating visuals, and optimized messaging that resonate with target audiences, maximizing engagement and impact.

Data Insights: Uncovering Opportunities for Growth

By extracting valuable insights from complex datasets, we enable our clients to make informed decisions and drive business growth. Our data-driven approach uncovers hidden patterns, identifies market trends, and keeps our clients ahead of the competition.

Physician Influencer Marketing: Building Credibility and Thought Leadership

We understand the influential role of physicians in the healthcare industry. With our specialized physician influencer marketing services, we connect pharma companies with influential doctors who shape opinions and drive brand awareness.

Through strategic partnerships with key opinion leaders (KOLs), we help clients build credibility, establish thought leadership, and enhance brand reputation.

Join Us in Transforming Pharma & Healthcare

To know more contact:

US: 1-925-217-7578
India: (+91)-9100379991
Email: [email]
Website: [website]

Frequently Asked Questions About Multiplier AI

Multiplier AI is a media company. Transforming Healthcare with Innovation Multiplier AI is a leading force in the Healthcare industry, providing cutting-edge solutions to global brands like Galderma, Abbott, Merck, Cipla, Mankind, and more.

Transforming Healthcare with Innovation Multiplier AI is a leading force in the Healthcare industry, providing cutting-edge solutions to global brands like Galderma, Abbott, Merck, Cipla, Mankind, and more. With a team of 70+ dedicated professionals, we specialize in Generative AI, data insights, an.

Multiplier AI has been operating since 2016. You can verify their legitimacy through their official website and social media presence.

Multiplier AI operates in the media sector of the cryptocurrency industry. Compare Multiplier AI with other media companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Multiplier AI, research their track record (operating since 2016), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Multiplier AI is based in Danville, California, USA, has been operating since 2016. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Multiplier AI is based in Danville, California, USA, North America, with offices in Danville, California, USA, Hyderabad, Telangana, IND.

Multiplier AI was founded in 2016. The company currently has 106 employees.

Multiplier AI Details

Multiplier AI Offices (6)

Multiplier AI Tags

More About Multiplier AI

Work Model Details

Employees work from physical offices.

Latest from Academy

DeXe Built a DAO Platform That Actually Ships Products

DeXe (DEXE) is a no-code DAO governance protocol whose DAO Studio lets anyone deploy and run a decentralized organization using more than sixty modular, audited smart contracts. DEXE traded around $13.59 with a market cap above $1.1 billion, up roughly 386% from its February lows, while protocol TVL climbed to $1.7 billion across more than one hundred DAOs. DeXe has shipped working software where most DAO tooling projects stalled, with audits from Cyfrin, Hacken, CertiK, and Ambisafe and staking yields reported up to 102% APR. Yet the holder base has stayed near 50,000 even as capital concentrated, raising a concentration question the price has yet to resolve. Regulatory tailwinds from MiCA and proposed U.S. rules could favor auditable on-chain governance, but execution still needs user growth to back the valuation.

Archie DuttonMay 24, 2026

8m read

Trading Analysis

WFI

MANA

FTT

Three Reasons WFI Outperformed Bitcoin in Q1 2026

WeFi (WFI) did something almost no small-cap managed in early 2026: it ran while Bitcoin stood still. WFI opened the year near $0.80 and pushed past $2.00 by late March, a gain of more than 150% while the largest cryptocurrency finished the quarter roughly flat. Three forces drove the move. A collaboration with Visa on on-chain banking and stablecoin payments gave the project mainstream validation. A flight toward utility-focused, compliance-checked DeFi pulled fresh capital into a token with real licenses, Fireblocks custody, and audited contracts. And institutions hunting small-cap infrastructure found a token with only 8.2% of supply circulating. The catch is everything the bears keep pointing at: thin daily volume, a 918 million token overhang still locked, and no proof that users are transacting in WFI rather than just parking stablecoins. With the first halving due in September, the real question is not whether WFI deserved its run, but whether it can survive what comes next.

Mia HallandMay 24, 2026

8m read

Altcoins

XCN

ENS

MKR

Onyxcoin Survived Collapse While Others Died

Onyxcoin (XCN) should not still exist. The protocol behind it was hacked twice through the same CompoundV2 precision bug, the second time for more than $3.8 million in September 2024, and dozens of similar forks simply died. Instead, XCN trades around $0.0049 with a $186 million market cap, 97% below its 2022 all-time high. What kept it alive was not a slick press release but a DAO that put the rebuild to an on-chain vote: new architecture, a fresh whitepaper, gas-free wallets, and the Goliath proof-of-stake Layer 1, whose mainnet went live on March 27, 2026. The catch is that shipping products and seeing them adopted are very different things. Infrastructure and price still do not match up, and a live governance proposal to end all future token unlocks could flip the supply story deflationary. For any Onyxcoin price prediction in 2026, the real question is whether the rebuilt community can generate organic demand, or whether XCN keeps trading on listing pumps and milestone hype.

Archie DuttonMay 23, 2026

9m read